Literature DB >> 18541216

Mycobacterium tuberculosis and the macrophage: maintaining a balance.

Jean Pieters1.   

Abstract

Mycobacterium tuberculosis is a highly efficient pathogen, killing millions of infected people annually. The capacity of M. tuberculosis to survive and cause disease is strongly correlated to their ability to escape immune defense mechanisms. In particular, M. tuberculosis has the remarkable capacity to survive within the hostile environment of the macrophage. Understanding M. tuberculosis virulence strategies will not only define novel targets for drug development but will also help to uncover previously unknown signaling pathways related to the host's response to M. tuberculosis infection.

Entities:  

Mesh:

Year:  2008        PMID: 18541216     DOI: 10.1016/j.chom.2008.05.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  173 in total

Review 1.  Carbon metabolism of intracellular bacterial pathogens and possible links to virulence.

Authors:  Wolfgang Eisenreich; Thomas Dandekar; Jürgen Heesemann; Werner Goebel
Journal:  Nat Rev Microbiol       Date:  2010-05-10       Impact factor: 60.633

Review 2.  Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design.

Authors:  Buka Samten; Xisheng Wang; Peter F Barnes
Journal:  Tuberculosis (Edinb)       Date:  2011-12-09       Impact factor: 3.131

Review 3.  The challenge of new drug discovery for tuberculosis.

Authors:  Anil Koul; Eric Arnoult; Nacer Lounis; Jerome Guillemont; Koen Andries
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

4.  Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses.

Authors:  Wei Chen; Yige Bao; Xuerong Chen; Jeremy Burton; Xueli Gong; Dongqing Gu; Youjun Mi; Lang Bao
Journal:  Med Microbiol Immunol       Date:  2015-08-30       Impact factor: 3.402

5.  Spinal tuberculosis occurring after a closed bursting fracture of the vertebrae.

Authors:  Bo Huang; Chang-Qing Li; Ying Zhuang; Jian-Ping Xu; Yue Zhou
Journal:  Eur Spine J       Date:  2012-01-26       Impact factor: 3.134

Review 6.  On guard: coronin proteins in innate and adaptive immunity.

Authors:  Jean Pieters; Philipp Müller; Rajesh Jayachandran
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

7.  Mycolates of Mycobacterium tuberculosis modulate the flow of cholesterol for bacillary proliferation in murine macrophages.

Authors:  Ilke Vermeulen; Mark Baird; Juma Al-Dulayymi; Muriel Smet; Jan Verschoor; Johan Grooten
Journal:  J Lipid Res       Date:  2017-02-13       Impact factor: 5.922

8.  Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.

Authors:  A Singh; A Mohan; A B Dey; D K Mitra
Journal:  Clin Exp Immunol       Date:  2016-11-24       Impact factor: 4.330

9.  Diagnosis of intestinal tuberculosis using a monoclonal antibody to Mycobacterium tuberculosis.

Authors:  Yasushi Ihama; Akira Hokama; Kenji Hibiya; Kazuto Kishimoto; Manabu Nakamoto; Tetsuo Hirata; Nagisa Kinjo; Haley L Cash; Futoshi Higa; Masao Tateyama; Fukunori Kinjo; Jiro Fujita
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 10.  The protective role of antibody responses during Mycobacterium tuberculosis infection.

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.